MAX and small cell lung carcinoma: Formal evidence for this hypothesis was provided in two SCLC mouse models, in which deletion of Max could either abrogate tumorigenesis if combined with a MYCL transgene, or favor it afterloss of the Rb1 and Trp53 tumors suppressors (Augert et al, 2020).